Search
for

    Sort by

    Research 31–60 of 222

    1. Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships Current Medicinal Chemistry · 2000 · 204 citations
    2. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients The American Journal of Medicine · 1992 · 116 citations
    3. The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function American Journal of Pathology · 2003 · 72 citations
    4. Characteristics of flutamide action on prostatic and testicular functions in the rat Journal of Steroid Biochemistry · 1988 · 30 citations
    5. Bone density is normal in male rats treated with finasteride. Endocrinology · 1995 · 29 citations
    6. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    7. Finasteride-related Leydig cell tumour: report of a case and literature review Andrologia · 2011 · 5 citations
    8. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 2012 · 2295 citations
    9. Is dehydroepiandrosterone a hormone? Journal of Endocrinology · 2005 · 403 citations
    10. Is COVID-19 Gender-sensitive? Journal of Neuroimmune Pharmacology · 2021 · 228 citations
    11. Gender differences in skin: A review of the literature Gender Medicine · 2007 · 152 citations
    12. Hormone therapy for transgender patients Translational Andrology and Urology · 2016 · 146 citations
    13. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    14. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation Expert Opinion on Drug Safety · 2012 · 71 citations
    15. Semen Parameters Among Transgender Women With a History of Hormonal Treatment Urology · 2019 · 68 citations
    16. Pathways to inflammation: acne pathophysiology European Journal of Dermatology · 2011 · 68 citations
    17. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications The Prostate · 1986 · 57 citations
    18. 46,XY DSD due to impaired androgen production 2010 · 54 citations
    19. Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases The Journal of Steroid Biochemistry and Molecular Biology · 2013 · 51 citations
    20. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013 · 48 citations
    21. Endocrine-skin interactions Journal of The American Academy of Dermatology · 1988 · 46 citations
    22. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    23. The Effect of 5 -Reductase Inhibitors on Erectile Function International Journal of Andrology · 2008 · 31 citations
    24. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink BMJ · 2016 · 30 citations
    25. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    26. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    27. Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection Therapeutic Advances in Endocrinology and Metabolism · 2021 · 21 citations
    28. The pathophysiology of delayed ejaculation Translational Andrology and Urology · 2016 · 21 citations
    29. Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy Journal of The American Academy of Dermatology · 2012 · 18 citations
    30. Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles Journal of Genetic Counseling · 2020 · 17 citations